2,5,8,11,14,17-Hexaoxanonadecan-19-amine

Catalog No.: 
ACRNFI248
CAS No.: 
184357-46-8
Molecular Formula: 
C13H29NO6
Molecular Weight: 
295.38
2,5,8,11,14,17-Hexaoxanonadecan-19-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$102.00In stockIn stock
5g98%$334.00In stockIn stock
25g98%$1560.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5,8,11,14,17-Hexaoxanonadecan-19-amine
IUPAC Name2,5,8,11,14,17-hexaoxanonadecan-19-amine
MDL No.MFCD16619273
Molecular FormulaC13H29NO6
Molecular Weight295.38
SMILESCOCCOCCOCCOCCOCCOCCN
InChI KeyJDTWBXXBTWYNAT-UHFFFAOYSA-N
Synonym2,5,8,11,14,17-Hexaoxanonadecan-19-amine;3,6,9,12,15,18-Hexaoxanonadecan-1-amine;MPEG6-NH2;m-PEG6-amine;Methyl-PEG6-amine;2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanamine;1-amino-2-[2-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)ethoxy]ethane;H2N-(CH2CH2O)6-Me
CAS No.184357-46-8
PubChem CID19973405

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H314
Precautionary Statement(s)
P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P405-P501

Synthetic Route by SureRoute

1. ACRNFI248 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNFI248 route product structure diagram
    ACRNFI248184357-46-8In Stock
Inquiry

2. ACRNFI248 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNFI248 route product structure diagram
    ACRNFI248184357-46-8In Stock
Inquiry

3. ACRNFI248 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNFI248 route product structure diagram
    ACRNFI248184357-46-8In Stock
Inquiry

Comments (0)